Global Recombinant Follicle Stimulating Hormone Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Recombinant FSH is produced through recombinant DNA technology. These products are pure and do not contain the 'contaminants' seen in urine extraction FSH. It is given subcutaneously with much less discomfort. Both human and genetically derived products are difficult to obtain and manufacture and are therefore expensive.
LPI (LP Information)' newest research report, the “Recombinant Follicle Stimulating Hormone Industry Forecast” looks at past sales and reviews total world Recombinant Follicle Stimulating Hormone sales in 2022, providing a comprehensive analysis by region and market sector of projected Recombinant Follicle Stimulating Hormone sales for 2023 through 2029. With Recombinant Follicle Stimulating Hormone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Follicle Stimulating Hormone industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Follicle Stimulating Hormone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Follicle Stimulating Hormone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Recombinant Follicle Stimulating Hormone market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Follicle Stimulating Hormone and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Follicle Stimulating Hormone.
The global Recombinant Follicle Stimulating Hormone market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Recombinant Follicle Stimulating Hormone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Recombinant Follicle Stimulating Hormone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Recombinant Follicle Stimulating Hormone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Recombinant Follicle Stimulating Hormone players cover Merck Serono, MSD, Techwell, GenSci, Gedeon Richter and Teva, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Follicle Stimulating Hormone market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Recombinant Follicle Stimulating Hormone market?
What factors are driving Recombinant Follicle Stimulating Hormone market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Recombinant Follicle Stimulating Hormone market opportunities vary by end market size?
How does Recombinant Follicle Stimulating Hormone break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Recombinant FSH is produced through recombinant DNA technology. These products are pure and do not contain the 'contaminants' seen in urine extraction FSH. It is given subcutaneously with much less discomfort. Both human and genetically derived products are difficult to obtain and manufacture and are therefore expensive.
LPI (LP Information)' newest research report, the “Recombinant Follicle Stimulating Hormone Industry Forecast” looks at past sales and reviews total world Recombinant Follicle Stimulating Hormone sales in 2022, providing a comprehensive analysis by region and market sector of projected Recombinant Follicle Stimulating Hormone sales for 2023 through 2029. With Recombinant Follicle Stimulating Hormone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Follicle Stimulating Hormone industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Follicle Stimulating Hormone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Follicle Stimulating Hormone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Recombinant Follicle Stimulating Hormone market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Follicle Stimulating Hormone and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Follicle Stimulating Hormone.
The global Recombinant Follicle Stimulating Hormone market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Recombinant Follicle Stimulating Hormone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Recombinant Follicle Stimulating Hormone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Recombinant Follicle Stimulating Hormone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Recombinant Follicle Stimulating Hormone players cover Merck Serono, MSD, Techwell, GenSci, Gedeon Richter and Teva, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Follicle Stimulating Hormone market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- 75IU
- 150IU
- Others
- Infertility Treatment
- Assisted Reproductive Technology
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck Serono
- MSD
- Techwell
- GenSci
- Gedeon Richter
- Teva
What is the 10-year outlook for the global Recombinant Follicle Stimulating Hormone market?
What factors are driving Recombinant Follicle Stimulating Hormone market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Recombinant Follicle Stimulating Hormone market opportunities vary by end market size?
How does Recombinant Follicle Stimulating Hormone break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant Follicle Stimulating Hormone Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Recombinant Follicle Stimulating Hormone by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Recombinant Follicle Stimulating Hormone by Country/Region, 2018, 2022 & 2029
2.2 Recombinant Follicle Stimulating Hormone Segment by Type
2.2.1 75IU
2.2.2 150IU
2.2.3 Others
2.3 Recombinant Follicle Stimulating Hormone Sales by Type
2.3.1 Global Recombinant Follicle Stimulating Hormone Sales Market Share by Type (2018-2023)
2.3.2 Global Recombinant Follicle Stimulating Hormone Revenue and Market Share by Type (2018-2023)
2.3.3 Global Recombinant Follicle Stimulating Hormone Sale Price by Type (2018-2023)
2.4 Recombinant Follicle Stimulating Hormone Segment by Application
2.4.1 Infertility Treatment
2.4.2 Assisted Reproductive Technology
2.5 Recombinant Follicle Stimulating Hormone Sales by Application
2.5.1 Global Recombinant Follicle Stimulating Hormone Sale Market Share by Application (2018-2023)
2.5.2 Global Recombinant Follicle Stimulating Hormone Revenue and Market Share by Application (2018-2023)
2.5.3 Global Recombinant Follicle Stimulating Hormone Sale Price by Application (2018-2023)
3 GLOBAL RECOMBINANT FOLLICLE STIMULATING HORMONE BY COMPANY
3.1 Global Recombinant Follicle Stimulating Hormone Breakdown Data by Company
3.1.1 Global Recombinant Follicle Stimulating Hormone Annual Sales by Company (2018-2023)
3.1.2 Global Recombinant Follicle Stimulating Hormone Sales Market Share by Company (2018-2023)
3.2 Global Recombinant Follicle Stimulating Hormone Annual Revenue by Company (2018-2023)
3.2.1 Global Recombinant Follicle Stimulating Hormone Revenue by Company (2018-2023)
3.2.2 Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Company (2018-2023)
3.3 Global Recombinant Follicle Stimulating Hormone Sale Price by Company
3.4 Key Manufacturers Recombinant Follicle Stimulating Hormone Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant Follicle Stimulating Hormone Product Location Distribution
3.4.2 Players Recombinant Follicle Stimulating Hormone Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RECOMBINANT FOLLICLE STIMULATING HORMONE BY GEOGRAPHIC REGION
4.1 World Historic Recombinant Follicle Stimulating Hormone Market Size by Geographic Region (2018-2023)
4.1.1 Global Recombinant Follicle Stimulating Hormone Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Recombinant Follicle Stimulating Hormone Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Recombinant Follicle Stimulating Hormone Market Size by Country/Region (2018-2023)
4.2.1 Global Recombinant Follicle Stimulating Hormone Annual Sales by Country/Region (2018-2023)
4.2.2 Global Recombinant Follicle Stimulating Hormone Annual Revenue by Country/Region (2018-2023)
4.3 Americas Recombinant Follicle Stimulating Hormone Sales Growth
4.4 APAC Recombinant Follicle Stimulating Hormone Sales Growth
4.5 Europe Recombinant Follicle Stimulating Hormone Sales Growth
4.6 Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Growth
5 AMERICAS
5.1 Americas Recombinant Follicle Stimulating Hormone Sales by Country
5.1.1 Americas Recombinant Follicle Stimulating Hormone Sales by Country (2018-2023)
5.1.2 Americas Recombinant Follicle Stimulating Hormone Revenue by Country (2018-2023)
5.2 Americas Recombinant Follicle Stimulating Hormone Sales by Type
5.3 Americas Recombinant Follicle Stimulating Hormone Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Follicle Stimulating Hormone Sales by Region
6.1.1 APAC Recombinant Follicle Stimulating Hormone Sales by Region (2018-2023)
6.1.2 APAC Recombinant Follicle Stimulating Hormone Revenue by Region (2018-2023)
6.2 APAC Recombinant Follicle Stimulating Hormone Sales by Type
6.3 APAC Recombinant Follicle Stimulating Hormone Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Recombinant Follicle Stimulating Hormone by Country
7.1.1 Europe Recombinant Follicle Stimulating Hormone Sales by Country (2018-2023)
7.1.2 Europe Recombinant Follicle Stimulating Hormone Revenue by Country (2018-2023)
7.2 Europe Recombinant Follicle Stimulating Hormone Sales by Type
7.3 Europe Recombinant Follicle Stimulating Hormone Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant Follicle Stimulating Hormone by Country
8.1.1 Middle East & Africa Recombinant Follicle Stimulating Hormone Sales by Country (2018-2023)
8.1.2 Middle East & Africa Recombinant Follicle Stimulating Hormone Revenue by Country (2018-2023)
8.2 Middle East & Africa Recombinant Follicle Stimulating Hormone Sales by Type
8.3 Middle East & Africa Recombinant Follicle Stimulating Hormone Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant Follicle Stimulating Hormone
10.3 Manufacturing Process Analysis of Recombinant Follicle Stimulating Hormone
10.4 Industry Chain Structure of Recombinant Follicle Stimulating Hormone
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant Follicle Stimulating Hormone Distributors
11.3 Recombinant Follicle Stimulating Hormone Customer
12 WORLD FORECAST REVIEW FOR RECOMBINANT FOLLICLE STIMULATING HORMONE BY GEOGRAPHIC REGION
12.1 Global Recombinant Follicle Stimulating Hormone Market Size Forecast by Region
12.1.1 Global Recombinant Follicle Stimulating Hormone Forecast by Region (2024-2029)
12.1.2 Global Recombinant Follicle Stimulating Hormone Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Recombinant Follicle Stimulating Hormone Forecast by Type
12.7 Global Recombinant Follicle Stimulating Hormone Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck Serono
13.1.1 Merck Serono Company Information
13.1.2 Merck Serono Recombinant Follicle Stimulating Hormone Product Portfolios and Specifications
13.1.3 Merck Serono Recombinant Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Serono Main Business Overview
13.1.5 Merck Serono Latest Developments
13.2 MSD
13.2.1 MSD Company Information
13.2.2 MSD Recombinant Follicle Stimulating Hormone Product Portfolios and Specifications
13.2.3 MSD Recombinant Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 MSD Main Business Overview
13.2.5 MSD Latest Developments
13.3 Techwell
13.3.1 Techwell Company Information
13.3.2 Techwell Recombinant Follicle Stimulating Hormone Product Portfolios and Specifications
13.3.3 Techwell Recombinant Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Techwell Main Business Overview
13.3.5 Techwell Latest Developments
13.4 GenSci
13.4.1 GenSci Company Information
13.4.2 GenSci Recombinant Follicle Stimulating Hormone Product Portfolios and Specifications
13.4.3 GenSci Recombinant Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 GenSci Main Business Overview
13.4.5 GenSci Latest Developments
13.5 Gedeon Richter
13.5.1 Gedeon Richter Company Information
13.5.2 Gedeon Richter Recombinant Follicle Stimulating Hormone Product Portfolios and Specifications
13.5.3 Gedeon Richter Recombinant Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Gedeon Richter Main Business Overview
13.5.5 Gedeon Richter Latest Developments
13.6 Teva
13.6.1 Teva Company Information
13.6.2 Teva Recombinant Follicle Stimulating Hormone Product Portfolios and Specifications
13.6.3 Teva Recombinant Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Teva Main Business Overview
13.6.5 Teva Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant Follicle Stimulating Hormone Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Recombinant Follicle Stimulating Hormone by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Recombinant Follicle Stimulating Hormone by Country/Region, 2018, 2022 & 2029
2.2 Recombinant Follicle Stimulating Hormone Segment by Type
2.2.1 75IU
2.2.2 150IU
2.2.3 Others
2.3 Recombinant Follicle Stimulating Hormone Sales by Type
2.3.1 Global Recombinant Follicle Stimulating Hormone Sales Market Share by Type (2018-2023)
2.3.2 Global Recombinant Follicle Stimulating Hormone Revenue and Market Share by Type (2018-2023)
2.3.3 Global Recombinant Follicle Stimulating Hormone Sale Price by Type (2018-2023)
2.4 Recombinant Follicle Stimulating Hormone Segment by Application
2.4.1 Infertility Treatment
2.4.2 Assisted Reproductive Technology
2.5 Recombinant Follicle Stimulating Hormone Sales by Application
2.5.1 Global Recombinant Follicle Stimulating Hormone Sale Market Share by Application (2018-2023)
2.5.2 Global Recombinant Follicle Stimulating Hormone Revenue and Market Share by Application (2018-2023)
2.5.3 Global Recombinant Follicle Stimulating Hormone Sale Price by Application (2018-2023)
3 GLOBAL RECOMBINANT FOLLICLE STIMULATING HORMONE BY COMPANY
3.1 Global Recombinant Follicle Stimulating Hormone Breakdown Data by Company
3.1.1 Global Recombinant Follicle Stimulating Hormone Annual Sales by Company (2018-2023)
3.1.2 Global Recombinant Follicle Stimulating Hormone Sales Market Share by Company (2018-2023)
3.2 Global Recombinant Follicle Stimulating Hormone Annual Revenue by Company (2018-2023)
3.2.1 Global Recombinant Follicle Stimulating Hormone Revenue by Company (2018-2023)
3.2.2 Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Company (2018-2023)
3.3 Global Recombinant Follicle Stimulating Hormone Sale Price by Company
3.4 Key Manufacturers Recombinant Follicle Stimulating Hormone Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant Follicle Stimulating Hormone Product Location Distribution
3.4.2 Players Recombinant Follicle Stimulating Hormone Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RECOMBINANT FOLLICLE STIMULATING HORMONE BY GEOGRAPHIC REGION
4.1 World Historic Recombinant Follicle Stimulating Hormone Market Size by Geographic Region (2018-2023)
4.1.1 Global Recombinant Follicle Stimulating Hormone Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Recombinant Follicle Stimulating Hormone Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Recombinant Follicle Stimulating Hormone Market Size by Country/Region (2018-2023)
4.2.1 Global Recombinant Follicle Stimulating Hormone Annual Sales by Country/Region (2018-2023)
4.2.2 Global Recombinant Follicle Stimulating Hormone Annual Revenue by Country/Region (2018-2023)
4.3 Americas Recombinant Follicle Stimulating Hormone Sales Growth
4.4 APAC Recombinant Follicle Stimulating Hormone Sales Growth
4.5 Europe Recombinant Follicle Stimulating Hormone Sales Growth
4.6 Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Growth
5 AMERICAS
5.1 Americas Recombinant Follicle Stimulating Hormone Sales by Country
5.1.1 Americas Recombinant Follicle Stimulating Hormone Sales by Country (2018-2023)
5.1.2 Americas Recombinant Follicle Stimulating Hormone Revenue by Country (2018-2023)
5.2 Americas Recombinant Follicle Stimulating Hormone Sales by Type
5.3 Americas Recombinant Follicle Stimulating Hormone Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Follicle Stimulating Hormone Sales by Region
6.1.1 APAC Recombinant Follicle Stimulating Hormone Sales by Region (2018-2023)
6.1.2 APAC Recombinant Follicle Stimulating Hormone Revenue by Region (2018-2023)
6.2 APAC Recombinant Follicle Stimulating Hormone Sales by Type
6.3 APAC Recombinant Follicle Stimulating Hormone Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Recombinant Follicle Stimulating Hormone by Country
7.1.1 Europe Recombinant Follicle Stimulating Hormone Sales by Country (2018-2023)
7.1.2 Europe Recombinant Follicle Stimulating Hormone Revenue by Country (2018-2023)
7.2 Europe Recombinant Follicle Stimulating Hormone Sales by Type
7.3 Europe Recombinant Follicle Stimulating Hormone Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant Follicle Stimulating Hormone by Country
8.1.1 Middle East & Africa Recombinant Follicle Stimulating Hormone Sales by Country (2018-2023)
8.1.2 Middle East & Africa Recombinant Follicle Stimulating Hormone Revenue by Country (2018-2023)
8.2 Middle East & Africa Recombinant Follicle Stimulating Hormone Sales by Type
8.3 Middle East & Africa Recombinant Follicle Stimulating Hormone Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant Follicle Stimulating Hormone
10.3 Manufacturing Process Analysis of Recombinant Follicle Stimulating Hormone
10.4 Industry Chain Structure of Recombinant Follicle Stimulating Hormone
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant Follicle Stimulating Hormone Distributors
11.3 Recombinant Follicle Stimulating Hormone Customer
12 WORLD FORECAST REVIEW FOR RECOMBINANT FOLLICLE STIMULATING HORMONE BY GEOGRAPHIC REGION
12.1 Global Recombinant Follicle Stimulating Hormone Market Size Forecast by Region
12.1.1 Global Recombinant Follicle Stimulating Hormone Forecast by Region (2024-2029)
12.1.2 Global Recombinant Follicle Stimulating Hormone Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Recombinant Follicle Stimulating Hormone Forecast by Type
12.7 Global Recombinant Follicle Stimulating Hormone Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck Serono
13.1.1 Merck Serono Company Information
13.1.2 Merck Serono Recombinant Follicle Stimulating Hormone Product Portfolios and Specifications
13.1.3 Merck Serono Recombinant Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Serono Main Business Overview
13.1.5 Merck Serono Latest Developments
13.2 MSD
13.2.1 MSD Company Information
13.2.2 MSD Recombinant Follicle Stimulating Hormone Product Portfolios and Specifications
13.2.3 MSD Recombinant Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 MSD Main Business Overview
13.2.5 MSD Latest Developments
13.3 Techwell
13.3.1 Techwell Company Information
13.3.2 Techwell Recombinant Follicle Stimulating Hormone Product Portfolios and Specifications
13.3.3 Techwell Recombinant Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Techwell Main Business Overview
13.3.5 Techwell Latest Developments
13.4 GenSci
13.4.1 GenSci Company Information
13.4.2 GenSci Recombinant Follicle Stimulating Hormone Product Portfolios and Specifications
13.4.3 GenSci Recombinant Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 GenSci Main Business Overview
13.4.5 GenSci Latest Developments
13.5 Gedeon Richter
13.5.1 Gedeon Richter Company Information
13.5.2 Gedeon Richter Recombinant Follicle Stimulating Hormone Product Portfolios and Specifications
13.5.3 Gedeon Richter Recombinant Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Gedeon Richter Main Business Overview
13.5.5 Gedeon Richter Latest Developments
13.6 Teva
13.6.1 Teva Company Information
13.6.2 Teva Recombinant Follicle Stimulating Hormone Product Portfolios and Specifications
13.6.3 Teva Recombinant Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Teva Main Business Overview
13.6.5 Teva Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Recombinant Follicle Stimulating Hormone Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Recombinant Follicle Stimulating Hormone Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 75IU
Table 4. Major Players of 150IU
Table 5. Major Players of Others
Table 6. Global Recombinant Follicle Stimulating Hormone Sales by Type (2018-2023) & (K Doses)
Table 7. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Type (2018-2023)
Table 8. Global Recombinant Follicle Stimulating Hormone Revenue by Type (2018-2023) & ($ million)
Table 9. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Type (2018-2023)
Table 10. Global Recombinant Follicle Stimulating Hormone Sale Price by Type (2018-2023) & (USD/Dose)
Table 11. Global Recombinant Follicle Stimulating Hormone Sales by Application (2018-2023) & (K Doses)
Table 12. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Application (2018-2023)
Table 13. Global Recombinant Follicle Stimulating Hormone Revenue by Application (2018-2023)
Table 14. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Application (2018-2023)
Table 15. Global Recombinant Follicle Stimulating Hormone Sale Price by Application (2018-2023) & (USD/Dose)
Table 16. Global Recombinant Follicle Stimulating Hormone Sales by Company (2018-2023) & (K Doses)
Table 17. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Company (2018-2023)
Table 18. Global Recombinant Follicle Stimulating Hormone Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Company (2018-2023)
Table 20. Global Recombinant Follicle Stimulating Hormone Sale Price by Company (2018-2023) & (USD/Dose)
Table 21. Key Manufacturers Recombinant Follicle Stimulating Hormone Producing Area Distribution and Sales Area
Table 22. Players Recombinant Follicle Stimulating Hormone Products Offered
Table 23. Recombinant Follicle Stimulating Hormone Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Recombinant Follicle Stimulating Hormone Sales by Geographic Region (2018-2023) & (K Doses)
Table 27. Global Recombinant Follicle Stimulating Hormone Sales Market Share Geographic Region (2018-2023)
Table 28. Global Recombinant Follicle Stimulating Hormone Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Recombinant Follicle Stimulating Hormone Sales by Country/Region (2018-2023) & (K Doses)
Table 31. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Country/Region (2018-2023)
Table 32. Global Recombinant Follicle Stimulating Hormone Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Recombinant Follicle Stimulating Hormone Sales by Country (2018-2023) & (K Doses)
Table 35. Americas Recombinant Follicle Stimulating Hormone Sales Market Share by Country (2018-2023)
Table 36. Americas Recombinant Follicle Stimulating Hormone Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Recombinant Follicle Stimulating Hormone Revenue Market Share by Country (2018-2023)
Table 38. Americas Recombinant Follicle Stimulating Hormone Sales by Type (2018-2023) & (K Doses)
Table 39. Americas Recombinant Follicle Stimulating Hormone Sales by Application (2018-2023) & (K Doses)
Table 40. APAC Recombinant Follicle Stimulating Hormone Sales by Region (2018-2023) & (K Doses)
Table 41. APAC Recombinant Follicle Stimulating Hormone Sales Market Share by Region (2018-2023)
Table 42. APAC Recombinant Follicle Stimulating Hormone Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Recombinant Follicle Stimulating Hormone Revenue Market Share by Region (2018-2023)
Table 44. APAC Recombinant Follicle Stimulating Hormone Sales by Type (2018-2023) & (K Doses)
Table 45. APAC Recombinant Follicle Stimulating Hormone Sales by Application (2018-2023) & (K Doses)
Table 46. Europe Recombinant Follicle Stimulating Hormone Sales by Country (2018-2023) & (K Doses)
Table 47. Europe Recombinant Follicle Stimulating Hormone Sales Market Share by Country (2018-2023)
Table 48. Europe Recombinant Follicle Stimulating Hormone Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Recombinant Follicle Stimulating Hormone Revenue Market Share by Country (2018-2023)
Table 50. Europe Recombinant Follicle Stimulating Hormone Sales by Type (2018-2023) & (K Doses)
Table 51. Europe Recombinant Follicle Stimulating Hormone Sales by Application (2018-2023) & (K Doses)
Table 52. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales by Country (2018-2023) & (K Doses)
Table 53. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Recombinant Follicle Stimulating Hormone Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Recombinant Follicle Stimulating Hormone Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales by Type (2018-2023) & (K Doses)
Table 57. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales by Application (2018-2023) & (K Doses)
Table 58. Key Market Drivers & Growth Opportunities of Recombinant Follicle Stimulating Hormone
Table 59. Key Market Challenges & Risks of Recombinant Follicle Stimulating Hormone
Table 60. Key Industry Trends of Recombinant Follicle Stimulating Hormone
Table 61. Recombinant Follicle Stimulating Hormone Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Recombinant Follicle Stimulating Hormone Distributors List
Table 64. Recombinant Follicle Stimulating Hormone Customer List
Table 65. Global Recombinant Follicle Stimulating Hormone Sales Forecast by Region (2024-2029) & (K Doses)
Table 66. Global Recombinant Follicle Stimulating Hormone Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Recombinant Follicle Stimulating Hormone Sales Forecast by Country (2024-2029) & (K Doses)
Table 68. Americas Recombinant Follicle Stimulating Hormone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Recombinant Follicle Stimulating Hormone Sales Forecast by Region (2024-2029) & (K Doses)
Table 70. APAC Recombinant Follicle Stimulating Hormone Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Recombinant Follicle Stimulating Hormone Sales Forecast by Country (2024-2029) & (K Doses)
Table 72. Europe Recombinant Follicle Stimulating Hormone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Forecast by Country (2024-2029) & (K Doses)
Table 74. Middle East & Africa Recombinant Follicle Stimulating Hormone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Recombinant Follicle Stimulating Hormone Sales Forecast by Type (2024-2029) & (K Doses)
Table 76. Global Recombinant Follicle Stimulating Hormone Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Recombinant Follicle Stimulating Hormone Sales Forecast by Application (2024-2029) & (K Doses)
Table 78. Global Recombinant Follicle Stimulating Hormone Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Merck Serono Basic Information, Recombinant Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 80. Merck Serono Recombinant Follicle Stimulating Hormone Product Portfolios and Specifications
Table 81. Merck Serono Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 82. Merck Serono Main Business
Table 83. Merck Serono Latest Developments
Table 84. MSD Basic Information, Recombinant Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 85. MSD Recombinant Follicle Stimulating Hormone Product Portfolios and Specifications
Table 86. MSD Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 87. MSD Main Business
Table 88. MSD Latest Developments
Table 89. Techwell Basic Information, Recombinant Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 90. Techwell Recombinant Follicle Stimulating Hormone Product Portfolios and Specifications
Table 91. Techwell Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 92. Techwell Main Business
Table 93. Techwell Latest Developments
Table 94. GenSci Basic Information, Recombinant Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 95. GenSci Recombinant Follicle Stimulating Hormone Product Portfolios and Specifications
Table 96. GenSci Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 97. GenSci Main Business
Table 98. GenSci Latest Developments
Table 99. Gedeon Richter Basic Information, Recombinant Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 100. Gedeon Richter Recombinant Follicle Stimulating Hormone Product Portfolios and Specifications
Table 101. Gedeon Richter Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 102. Gedeon Richter Main Business
Table 103. Gedeon Richter Latest Developments
Table 104. Teva Basic Information, Recombinant Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 105. Teva Recombinant Follicle Stimulating Hormone Product Portfolios and Specifications
Table 106. Teva Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 107. Teva Main Business
Table 108. Teva Latest Developments
Table 1. Recombinant Follicle Stimulating Hormone Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Recombinant Follicle Stimulating Hormone Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 75IU
Table 4. Major Players of 150IU
Table 5. Major Players of Others
Table 6. Global Recombinant Follicle Stimulating Hormone Sales by Type (2018-2023) & (K Doses)
Table 7. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Type (2018-2023)
Table 8. Global Recombinant Follicle Stimulating Hormone Revenue by Type (2018-2023) & ($ million)
Table 9. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Type (2018-2023)
Table 10. Global Recombinant Follicle Stimulating Hormone Sale Price by Type (2018-2023) & (USD/Dose)
Table 11. Global Recombinant Follicle Stimulating Hormone Sales by Application (2018-2023) & (K Doses)
Table 12. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Application (2018-2023)
Table 13. Global Recombinant Follicle Stimulating Hormone Revenue by Application (2018-2023)
Table 14. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Application (2018-2023)
Table 15. Global Recombinant Follicle Stimulating Hormone Sale Price by Application (2018-2023) & (USD/Dose)
Table 16. Global Recombinant Follicle Stimulating Hormone Sales by Company (2018-2023) & (K Doses)
Table 17. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Company (2018-2023)
Table 18. Global Recombinant Follicle Stimulating Hormone Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Company (2018-2023)
Table 20. Global Recombinant Follicle Stimulating Hormone Sale Price by Company (2018-2023) & (USD/Dose)
Table 21. Key Manufacturers Recombinant Follicle Stimulating Hormone Producing Area Distribution and Sales Area
Table 22. Players Recombinant Follicle Stimulating Hormone Products Offered
Table 23. Recombinant Follicle Stimulating Hormone Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Recombinant Follicle Stimulating Hormone Sales by Geographic Region (2018-2023) & (K Doses)
Table 27. Global Recombinant Follicle Stimulating Hormone Sales Market Share Geographic Region (2018-2023)
Table 28. Global Recombinant Follicle Stimulating Hormone Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Recombinant Follicle Stimulating Hormone Sales by Country/Region (2018-2023) & (K Doses)
Table 31. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Country/Region (2018-2023)
Table 32. Global Recombinant Follicle Stimulating Hormone Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Recombinant Follicle Stimulating Hormone Sales by Country (2018-2023) & (K Doses)
Table 35. Americas Recombinant Follicle Stimulating Hormone Sales Market Share by Country (2018-2023)
Table 36. Americas Recombinant Follicle Stimulating Hormone Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Recombinant Follicle Stimulating Hormone Revenue Market Share by Country (2018-2023)
Table 38. Americas Recombinant Follicle Stimulating Hormone Sales by Type (2018-2023) & (K Doses)
Table 39. Americas Recombinant Follicle Stimulating Hormone Sales by Application (2018-2023) & (K Doses)
Table 40. APAC Recombinant Follicle Stimulating Hormone Sales by Region (2018-2023) & (K Doses)
Table 41. APAC Recombinant Follicle Stimulating Hormone Sales Market Share by Region (2018-2023)
Table 42. APAC Recombinant Follicle Stimulating Hormone Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Recombinant Follicle Stimulating Hormone Revenue Market Share by Region (2018-2023)
Table 44. APAC Recombinant Follicle Stimulating Hormone Sales by Type (2018-2023) & (K Doses)
Table 45. APAC Recombinant Follicle Stimulating Hormone Sales by Application (2018-2023) & (K Doses)
Table 46. Europe Recombinant Follicle Stimulating Hormone Sales by Country (2018-2023) & (K Doses)
Table 47. Europe Recombinant Follicle Stimulating Hormone Sales Market Share by Country (2018-2023)
Table 48. Europe Recombinant Follicle Stimulating Hormone Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Recombinant Follicle Stimulating Hormone Revenue Market Share by Country (2018-2023)
Table 50. Europe Recombinant Follicle Stimulating Hormone Sales by Type (2018-2023) & (K Doses)
Table 51. Europe Recombinant Follicle Stimulating Hormone Sales by Application (2018-2023) & (K Doses)
Table 52. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales by Country (2018-2023) & (K Doses)
Table 53. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Recombinant Follicle Stimulating Hormone Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Recombinant Follicle Stimulating Hormone Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales by Type (2018-2023) & (K Doses)
Table 57. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales by Application (2018-2023) & (K Doses)
Table 58. Key Market Drivers & Growth Opportunities of Recombinant Follicle Stimulating Hormone
Table 59. Key Market Challenges & Risks of Recombinant Follicle Stimulating Hormone
Table 60. Key Industry Trends of Recombinant Follicle Stimulating Hormone
Table 61. Recombinant Follicle Stimulating Hormone Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Recombinant Follicle Stimulating Hormone Distributors List
Table 64. Recombinant Follicle Stimulating Hormone Customer List
Table 65. Global Recombinant Follicle Stimulating Hormone Sales Forecast by Region (2024-2029) & (K Doses)
Table 66. Global Recombinant Follicle Stimulating Hormone Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Recombinant Follicle Stimulating Hormone Sales Forecast by Country (2024-2029) & (K Doses)
Table 68. Americas Recombinant Follicle Stimulating Hormone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Recombinant Follicle Stimulating Hormone Sales Forecast by Region (2024-2029) & (K Doses)
Table 70. APAC Recombinant Follicle Stimulating Hormone Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Recombinant Follicle Stimulating Hormone Sales Forecast by Country (2024-2029) & (K Doses)
Table 72. Europe Recombinant Follicle Stimulating Hormone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Forecast by Country (2024-2029) & (K Doses)
Table 74. Middle East & Africa Recombinant Follicle Stimulating Hormone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Recombinant Follicle Stimulating Hormone Sales Forecast by Type (2024-2029) & (K Doses)
Table 76. Global Recombinant Follicle Stimulating Hormone Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Recombinant Follicle Stimulating Hormone Sales Forecast by Application (2024-2029) & (K Doses)
Table 78. Global Recombinant Follicle Stimulating Hormone Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Merck Serono Basic Information, Recombinant Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 80. Merck Serono Recombinant Follicle Stimulating Hormone Product Portfolios and Specifications
Table 81. Merck Serono Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 82. Merck Serono Main Business
Table 83. Merck Serono Latest Developments
Table 84. MSD Basic Information, Recombinant Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 85. MSD Recombinant Follicle Stimulating Hormone Product Portfolios and Specifications
Table 86. MSD Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 87. MSD Main Business
Table 88. MSD Latest Developments
Table 89. Techwell Basic Information, Recombinant Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 90. Techwell Recombinant Follicle Stimulating Hormone Product Portfolios and Specifications
Table 91. Techwell Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 92. Techwell Main Business
Table 93. Techwell Latest Developments
Table 94. GenSci Basic Information, Recombinant Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 95. GenSci Recombinant Follicle Stimulating Hormone Product Portfolios and Specifications
Table 96. GenSci Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 97. GenSci Main Business
Table 98. GenSci Latest Developments
Table 99. Gedeon Richter Basic Information, Recombinant Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 100. Gedeon Richter Recombinant Follicle Stimulating Hormone Product Portfolios and Specifications
Table 101. Gedeon Richter Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 102. Gedeon Richter Main Business
Table 103. Gedeon Richter Latest Developments
Table 104. Teva Basic Information, Recombinant Follicle Stimulating Hormone Manufacturing Base, Sales Area and Its Competitors
Table 105. Teva Recombinant Follicle Stimulating Hormone Product Portfolios and Specifications
Table 106. Teva Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 107. Teva Main Business
Table 108. Teva Latest Developments
LIST OF FIGURES
Figure 1. Picture of Recombinant Follicle Stimulating Hormone
Figure 2. Recombinant Follicle Stimulating Hormone Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant Follicle Stimulating Hormone Sales Growth Rate 2018-2029 (K Doses)
Figure 7. Global Recombinant Follicle Stimulating Hormone Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Recombinant Follicle Stimulating Hormone Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 75IU
Figure 10. Product Picture of 150IU
Figure 11. Product Picture of Others
Figure 12. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Type in 2022
Figure 13. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Type (2018-2023)
Figure 14. Recombinant Follicle Stimulating Hormone Consumed in Infertility Treatment
Figure 15. Global Recombinant Follicle Stimulating Hormone Market: Infertility Treatment (2018-2023) & (K Doses)
Figure 16. Recombinant Follicle Stimulating Hormone Consumed in Assisted Reproductive Technology
Figure 17. Global Recombinant Follicle Stimulating Hormone Market: Assisted Reproductive Technology (2018-2023) & (K Doses)
Figure 18. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Application (2022)
Figure 19. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Application in 2022
Figure 20. Recombinant Follicle Stimulating Hormone Sales Market by Company in 2022 (K Doses)
Figure 21. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Company in 2022
Figure 22. Recombinant Follicle Stimulating Hormone Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Company in 2022
Figure 24. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Recombinant Follicle Stimulating Hormone Sales 2018-2023 (K Doses)
Figure 27. Americas Recombinant Follicle Stimulating Hormone Revenue 2018-2023 ($ Millions)
Figure 28. APAC Recombinant Follicle Stimulating Hormone Sales 2018-2023 (K Doses)
Figure 29. APAC Recombinant Follicle Stimulating Hormone Revenue 2018-2023 ($ Millions)
Figure 30. Europe Recombinant Follicle Stimulating Hormone Sales 2018-2023 (K Doses)
Figure 31. Europe Recombinant Follicle Stimulating Hormone Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales 2018-2023 (K Doses)
Figure 33. Middle East & Africa Recombinant Follicle Stimulating Hormone Revenue 2018-2023 ($ Millions)
Figure 34. Americas Recombinant Follicle Stimulating Hormone Sales Market Share by Country in 2022
Figure 35. Americas Recombinant Follicle Stimulating Hormone Revenue Market Share by Country in 2022
Figure 36. Americas Recombinant Follicle Stimulating Hormone Sales Market Share by Type (2018-2023)
Figure 37. Americas Recombinant Follicle Stimulating Hormone Sales Market Share by Application (2018-2023)
Figure 38. United States Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Recombinant Follicle Stimulating Hormone Sales Market Share by Region in 2022
Figure 43. APAC Recombinant Follicle Stimulating Hormone Revenue Market Share by Regions in 2022
Figure 44. APAC Recombinant Follicle Stimulating Hormone Sales Market Share by Type (2018-2023)
Figure 45. APAC Recombinant Follicle Stimulating Hormone Sales Market Share by Application (2018-2023)
Figure 46. China Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Recombinant Follicle Stimulating Hormone Sales Market Share by Country in 2022
Figure 54. Europe Recombinant Follicle Stimulating Hormone Revenue Market Share by Country in 2022
Figure 55. Europe Recombinant Follicle Stimulating Hormone Sales Market Share by Type (2018-2023)
Figure 56. Europe Recombinant Follicle Stimulating Hormone Sales Market Share by Application (2018-2023)
Figure 57. Germany Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Recombinant Follicle Stimulating Hormone Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Market Share by Application (2018-2023)
Figure 66. Egypt Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Recombinant Follicle Stimulating Hormone in 2022
Figure 72. Manufacturing Process Analysis of Recombinant Follicle Stimulating Hormone
Figure 73. Industry Chain Structure of Recombinant Follicle Stimulating Hormone
Figure 74. Channels of Distribution
Figure 75. Global Recombinant Follicle Stimulating Hormone Sales Market Forecast by Region (2024-2029)
Figure 76. Global Recombinant Follicle Stimulating Hormone Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Recombinant Follicle Stimulating Hormone Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Recombinant Follicle Stimulating Hormone Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Recombinant Follicle Stimulating Hormone Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Recombinant Follicle Stimulating Hormone Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Recombinant Follicle Stimulating Hormone
Figure 2. Recombinant Follicle Stimulating Hormone Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant Follicle Stimulating Hormone Sales Growth Rate 2018-2029 (K Doses)
Figure 7. Global Recombinant Follicle Stimulating Hormone Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Recombinant Follicle Stimulating Hormone Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 75IU
Figure 10. Product Picture of 150IU
Figure 11. Product Picture of Others
Figure 12. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Type in 2022
Figure 13. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Type (2018-2023)
Figure 14. Recombinant Follicle Stimulating Hormone Consumed in Infertility Treatment
Figure 15. Global Recombinant Follicle Stimulating Hormone Market: Infertility Treatment (2018-2023) & (K Doses)
Figure 16. Recombinant Follicle Stimulating Hormone Consumed in Assisted Reproductive Technology
Figure 17. Global Recombinant Follicle Stimulating Hormone Market: Assisted Reproductive Technology (2018-2023) & (K Doses)
Figure 18. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Application (2022)
Figure 19. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Application in 2022
Figure 20. Recombinant Follicle Stimulating Hormone Sales Market by Company in 2022 (K Doses)
Figure 21. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Company in 2022
Figure 22. Recombinant Follicle Stimulating Hormone Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Company in 2022
Figure 24. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Recombinant Follicle Stimulating Hormone Sales 2018-2023 (K Doses)
Figure 27. Americas Recombinant Follicle Stimulating Hormone Revenue 2018-2023 ($ Millions)
Figure 28. APAC Recombinant Follicle Stimulating Hormone Sales 2018-2023 (K Doses)
Figure 29. APAC Recombinant Follicle Stimulating Hormone Revenue 2018-2023 ($ Millions)
Figure 30. Europe Recombinant Follicle Stimulating Hormone Sales 2018-2023 (K Doses)
Figure 31. Europe Recombinant Follicle Stimulating Hormone Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales 2018-2023 (K Doses)
Figure 33. Middle East & Africa Recombinant Follicle Stimulating Hormone Revenue 2018-2023 ($ Millions)
Figure 34. Americas Recombinant Follicle Stimulating Hormone Sales Market Share by Country in 2022
Figure 35. Americas Recombinant Follicle Stimulating Hormone Revenue Market Share by Country in 2022
Figure 36. Americas Recombinant Follicle Stimulating Hormone Sales Market Share by Type (2018-2023)
Figure 37. Americas Recombinant Follicle Stimulating Hormone Sales Market Share by Application (2018-2023)
Figure 38. United States Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Recombinant Follicle Stimulating Hormone Sales Market Share by Region in 2022
Figure 43. APAC Recombinant Follicle Stimulating Hormone Revenue Market Share by Regions in 2022
Figure 44. APAC Recombinant Follicle Stimulating Hormone Sales Market Share by Type (2018-2023)
Figure 45. APAC Recombinant Follicle Stimulating Hormone Sales Market Share by Application (2018-2023)
Figure 46. China Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Recombinant Follicle Stimulating Hormone Sales Market Share by Country in 2022
Figure 54. Europe Recombinant Follicle Stimulating Hormone Revenue Market Share by Country in 2022
Figure 55. Europe Recombinant Follicle Stimulating Hormone Sales Market Share by Type (2018-2023)
Figure 56. Europe Recombinant Follicle Stimulating Hormone Sales Market Share by Application (2018-2023)
Figure 57. Germany Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Recombinant Follicle Stimulating Hormone Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Market Share by Application (2018-2023)
Figure 66. Egypt Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Recombinant Follicle Stimulating Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Recombinant Follicle Stimulating Hormone in 2022
Figure 72. Manufacturing Process Analysis of Recombinant Follicle Stimulating Hormone
Figure 73. Industry Chain Structure of Recombinant Follicle Stimulating Hormone
Figure 74. Channels of Distribution
Figure 75. Global Recombinant Follicle Stimulating Hormone Sales Market Forecast by Region (2024-2029)
Figure 76. Global Recombinant Follicle Stimulating Hormone Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Recombinant Follicle Stimulating Hormone Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Recombinant Follicle Stimulating Hormone Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Recombinant Follicle Stimulating Hormone Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Recombinant Follicle Stimulating Hormone Revenue Market Share Forecast by Application (2024-2029)
